Thrombocytopenia 2

Common Name(s)

Thrombocytopenia 2

Thrombocytopenia-2 is an autosomal dominant nonsyndromic disorder characterized by decreased numbers of normal platelets, resulting in a mild bleeding tendency. Laboratory studies show no defects in platelet function or morphology, and bone marrow examination shows normal numbers of megakaryocytes and normal maturation stages, suggesting defective platelet production or release (summary by {18:Pippucci et al., 2011}).
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Thrombocytopenia 2" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Thrombocytopenia 2" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Thrombocytopenia 2" returned 8 free, full-text research articles on human participants. First 3 results:

Severe thrombocytopenia due to repaglinide in a patient with type 2 diabetes.
 

Author(s): Hisayuki Katsuyama, Chika Hiraishi, Yuki Hakoshima, Hidekatsu Yanai

Journal: Diabetes Care. 2013 Mar;36(3):e36.

 

Last Updated: 22 Feb 2013

Go To URL
Imbalance of angiopoietin-1 and angiopoetin-2 in severe dengue and relationship with thrombocytopenia, endothelial activation, and vascular stability.
 

Author(s): Meta Michels, André J A M van der Ven, Kis Djamiatun, Rob Fijnheer, Philip G de Groot, Arjan W Griffioen, Silvie Sebastian, Sultana M H Faradz, Quirijn de Mast

Journal: Am. J. Trop. Med. Hyg.. 2012 Nov;87(5):943-6.

 

The pathogenesis of plasma leakage during dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS) is largely unknown. Angiopoietins are key regulators of vascular integrity: Angiopoietin-1 is stored in platelets and maintains vascular integrity, and endothelium-derived angiopoietin-2 ...

Last Updated: 8 Nov 2012

Go To URL
[Immune thrombocytopenia following successful chemotherapy of acute leukemia: report of 2 cases].
 

Author(s): Li Guo, Hua Song, Jun-Qing Mao, Yong-Min Tang

Journal: Zhongguo Dang Dai Er Ke Za Zhi. 2012 Jun;14(6):464-5.

 

Last Updated: 28 Jun 2012

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Thrombocytopenia 2" returned 0 free, full-text review articles on human participants.

 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

A Pilot Study of a Thrombopoietin-Receptor Agonist, Eltrombopag, in Patients With Low to Int-2 Risk Myelodysplastic Syndrome (MDS)
 

Status: Recruiting

Condition Summary: Myelodysplastic Syndromes; Thrombocytopenia

 

Last Updated: 10 Apr 2015

Go to URL